전자담배 액상의 핵심 성분인 니코틴 염, 배합 개선 연구 진행 2025년 한 해 동안 제품 액상, 에어로졸, 소재, 신뢰성에 대해 13만 6000건 이상의 테스트 실시 300가지 테스트 절차 표준화 전 세계적으로 승인된 900건 이상의 특허를 바탕으로 지속적인 혁신과 기술 적용 런던 2025년 12월 10일 -- 세계적인 전자담배 브랜드 엘프바•로스트마리는 오늘 최신 R&D 성과를 발표하며, 액상 배합에 관한 선구적인 연구, 포괄적인 특허 포트폴리오, 확대된 테스트 프로토콜 등을 공개했다. 두 브랜드는 설립 초기부터 제품 개발에 과학 주도형 접근 방식을 적용해 왔으며, 매년 수백만 파운드에 달하는 R&D 투자를 단행하고 있다. 엘프바•로스트마리의 사무엘 푸(Samuel Fu) R&D 엔지니어링 총괄 이사는 "철저한 테스트는 우리 R&D 운영의 핵심"이라며 "2025년 한 해 동안 최종 제품, 액상, 에어로졸, 소재에 대해 13만 6000건 이상의 테스트를 수행했으며, 이는 더 높은 안전 기준을 향한 장기적인
[ 메디채널 김갑성 기자 ] -Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, double-blind, placebo-controlled, multicenter Phase III clinical trial. HONG KONG, Dec. 10, 2025 -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that its New Drug Application (NDA) for denifanstat (ASC40), a first-in-class, once-daily oral small molecule fatty acid synthase (FASN) inhibitor for the treatment of moderate-to-severe acne vulgaris, h
ZUG, Switzerland, Dec. 10, 2025 -- Berlin Heals Holding AG (Zug, Switzerland) is pleased to announce the appointment of Rob ten Hoedt as the new Chairman of the Board of Directors. "We are thrilled to welcome someone of Rob ten Hoedt's caliber to the Board," said Marko Bagaric, Co-founder and Member of the Board of Directors. "His global impact on healthcare systems and deep expertise in medical technology will positively affect our progress and give us even more momentum for the exciting year ahead." Rob ten Hoedt brings more than three decades of gl
Nicotine salts, the key vape e-liquid ingredient, studied to improve formulations Over 136,000 tests run in 2025 on product e-liquid, aerosol, material, and reliability 300 testing procedures deployed as standard Continuous innovation and technology applications powered by over 900 patents granted globally LONDON, Dec. 10, 2025 -- World-leading vaping brands ELFBAR and LOST MARY today shared the latest R&D breakthroughs, featuring pioneering research on e-liquid formulations, an all-inclusive patent portfolio, and expanded testing protocols.
SUZHOU, China, Dec. 10, 2025 -- On December 8, 2025, Alphamab Oncology (Stock Code: 9966.HK) successfully held its "Stay True to Our Original Aspiration, Forge Ahead into the Future" 2025 R&D Day in Shanghai. The event focused on the latest advancements in the field of antibody-drug conjugates (ADCs), comprehensively showcasing the company's R&D achievements in bispecific ADCs and dual-payload ADCs. It also shared a highly differentiated and globally competitive product pipeline and clinical development strategy, while outlining the multidimensional evolution of its world-le
DKSH Business Unit Healthcare Launches a three-part whitepaper series to help healthcare and life science companies explore industry trends and current market pressures to re-think commercial go-to market approaches in the Asia Pacific region. The whitepaper series demonstrates how strategic Commercial Outsourcing partnerships are evolving to deliver sustainable growth, resource agility, and improved patient access – successfully harnessing the region's growing USD 10 billion healthcare outsourcing opportunity. SINGAPORE, Dec. 10, 2025 -- DKSH Business Unit Healthcare has devel
Demonstration underscores Europe's commitment to secure, resilient, multi-orbit military satellite communications SINT-NIKLAAS, Belgium, Dec. 10, 2025 -- ST Engineering iDirect's EU Satcom Centre of Excellence, ST Engineering iDirect Europe, based in Sint-Niklaas, Belgium, today announced that the European Protected Waveform (EPW) consortium has successfully completed over-the-air testing, marking a critical milestone in Europe's pursuit of strategic autonomy in secure military communications. Conducted on November 26-27, 2025 at Universität der Bundeswehr München, Ge
KUALA LUMPUR, Malaysia, Dec. 10, 2025 -- Ddrops® participated in the Dear Mom x Ddrops® event, hosted by Innity Group, at IPC Shopping Centre, Malaysia, to engage with modern mothers and emphasize the importance of maternal support, emotional well-being, and self-care. Reflecting the realities of motherhood today, the event featured interactive zones, including the Self-Love Consultation Booth, Sponsored Brands Experience Zone, Dear Me Reflection Wall, and Creator Photo Zone, offering mothers a space to connect, share experiences, and rediscover themselves beyond caregiving. &n
SINGAPORE, Dec. 10, 2025 -- Beijing 101 Hair Consultants is thrilled to announce the launch of its latest treatment innovation – the Tri-Action Scalp Revival Treatment – a systematic, multi-technology hair and scalp treatment that cleanses, nourishes, and rejuvenates the scalp through a defined sequence of professionally guided steps. This new treatment reinforces Beijing 101's pledge to provide effective, state-of-the-art treatment solutions for hair and scalp issues, with Traditional Chinese Medicine (TCM) principles. Developed with precision and a clear methodology, the Tri-
KUALA LUMPUR, Malaysia, Dec. 10, 2025 -- Malaysia Healthcare Travel Council (MHTC) marked a major milestone in its medical tourism journey today with the announcement of the Winner of the Flagship Medical Tourism Hospital (FMTH) Programme, an initiative initiated and led by the Malaysia Healthcare Travel Council (MHTC) to elevate Malaysia's position as the preferred medical tourism destination in the world. The announcement was made during the FMTH 2025 Award Ceremony, held at M Resort & Hotel Kuala Lumpur. The event was officiated by YB Datuk Seri Dr. Dzulkef